Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Morin

Showing results (291-300 of 512) with videos related to

Pageof 52
Sort By:
Journal of Theoretical Biology|October 1, 1974
On the mechanism of interaction between histone II B1 and DNA and histone II B2 and DNAJ R Smythies, F Benington, R J Bradley, et al.
Journal of Robotic Surgery|May 1, 2024
Temporal and institutional trends in robotic surgeryA Pordal, J D Guerra, D Morin, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Trimetazidine counteracts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial functionA Elimadi, A Settaf, D Morin, et al.
The American Journal of Sports Medicine|March 1, 1996
The superiority of magnetic resonance imaging in differentiating the cause of hip pain in endurance athletesA Y Shin, W D Morin, J D Gorman, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1991
Blood binding of selezen (imidazole salicylate) in manR Zini, D Morin, G C Acuto, et al.
Applied Microbiology and Biotechnology|September 12, 2007
Biofilms of As(III)-oxidising bacteria: formation and activity studies for bioremediation process developmentC Michel, M Jean, S Coulon, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
Comparison of the effects of cyclosporine A and trimetazidine on Ca(2+)-dependent mitochondrial swellingA Elimadi, D Morin, R Sapena, et al.
Annales De Radiologie|April 1, 1984
Intracoronary thrombolysis in the treatment of acute myocardial infarctionA Essinger, U Sigwart, M Gbric, et al.
FEBS Letters|January 19, 1999
The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activitiesD Morin, N Cotte, M N Balestre, et al.
European Journal of Pharmacology|October 6, 2000
S-15176 reduces the hepatic injury in rats subjected to experimental ischemia and reperfusionA Settaf, M Zahidy, A Elimadi, et al.
Pageof 52

Showing results (291-300 of 512) with videos related to

Sort By:
Pageof 52
Journal of Theoretical Biology|October 1, 1974
On the mechanism of interaction between histone II B1 and DNA and histone II B2 and DNAJ R Smythies, F Benington, R J Bradley, et al.
Journal of Robotic Surgery|May 1, 2024
Temporal and institutional trends in robotic surgeryA Pordal, J D Guerra, D Morin, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 10, 1998
Trimetazidine counteracts the hepatic injury associated with ischemia-reperfusion by preserving mitochondrial functionA Elimadi, A Settaf, D Morin, et al.
The American Journal of Sports Medicine|March 1, 1996
The superiority of magnetic resonance imaging in differentiating the cause of hip pain in endurance athletesA Y Shin, W D Morin, J D Gorman, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|June 1, 1991
Blood binding of selezen (imidazole salicylate) in manR Zini, D Morin, G C Acuto, et al.
Applied Microbiology and Biotechnology|September 12, 2007
Biofilms of As(III)-oxidising bacteria: formation and activity studies for bioremediation process developmentC Michel, M Jean, S Coulon, et al.
Fundamental & Clinical Pharmacology|January 1, 1997
Comparison of the effects of cyclosporine A and trimetazidine on Ca(2+)-dependent mitochondrial swellingA Elimadi, D Morin, R Sapena, et al.
Annales De Radiologie|April 1, 1984
Intracoronary thrombolysis in the treatment of acute myocardial infarctionA Essinger, U Sigwart, M Gbric, et al.
FEBS Letters|January 19, 1999
The D136A mutation of the V2 vasopressin receptor induces a constitutive activity which permits discrimination between antagonists with partial agonist and inverse agonist activitiesD Morin, N Cotte, M N Balestre, et al.
European Journal of Pharmacology|October 6, 2000
S-15176 reduces the hepatic injury in rats subjected to experimental ischemia and reperfusionA Settaf, M Zahidy, A Elimadi, et al.
Pageof 52